Emergent Biosolutions Total Assets

Emergent Biosolutions (EBS) currently reports a total assets of $1.3B as of March 2026. That compares with $1.4B in the prior-year period — down 7.4% year over year. Use the charts on this page to explore Emergent Biosolutions's total assets history and peer comparisons.

Emergent Biosolutions's total assets decreased from $1.4B to $1.3B — a 7.4% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Emergent Biosolutions reported $1.3B in total assets as of March 2026. That compares with $1.4B in the prior-year period — down 7.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $1.3B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Emergent Biosolutions, and consider following EBS for alerts when major investors trade the stock.

Emergent Biosolutions is classified in the Healthcare sector. On total assets, it currently shows $1.3B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EBS with unrelated industries.